mhra

/mhra

MHRA Drug Safety Update: February 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 7 February 2024) has been published and includes articles on: Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) Letters and medicine recalls sent [...]

The post MHRA Drug Safety Update: February 2024 appeared first on Community Pharmacy England.

By |February 20th, 2024|drug safety, Lexpos News, mhra, safety|Comments Off on MHRA Drug Safety Update: February 2024

MHRA Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB)

Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB) Drug alert number: EL (23)A/01 Date issued: 3 January 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Bylvay 1200 micrograms Hard Capsules, PLGB 36216/0004 Batch number Expiry date Pack size First distributed [...]

The post MHRA Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB) appeared first on PSNC Website.

By |January 3rd, 2023|class 4, defect, Lexpos News, mhra|Comments Off on MHRA Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB)

MHRA Class 4 Medicines Defect Information: Epiduo 0.1% / 2.5% gel (Galderma (U.K.) Limited)

Class 4 Medicines Defect Information: Epiduo 0.1% / 2.5% gel (45 g) (Galderma (U.K.) Limited) Drug alert number: EL (22)A/52 Date issued: 19 December 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Epiduo 0.1% / 2.5% gel (45 g), PL 10590/0057 – SNOMED code [...]

The post MHRA Class 4 Medicines Defect Information: Epiduo 0.1% / 2.5% gel (Galderma (U.K.) Limited) appeared first on PSNC Website.

By |December 19th, 2022|class 4, drug safety, Lexpos News, mhra|Comments Off on MHRA Class 4 Medicines Defect Information: Epiduo 0.1% / 2.5% gel (Galderma (U.K.) Limited)